These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8635082)

  • 1. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet?
    Schnitt SJ; Harris JR; Smith BL
    Cancer; 1996 Jun; 77(11):2189-92. PubMed ID: 8635082
    [No Abstract]   [Full Text] [Related]  

  • 2. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of ductal carcinoma in situ of the breast. Provincial Breast Cancer Disease Site Group.
    Wright JR; Whelan TJ; McCready DR; O'Malley FP
    Cancer Prev Control; 1998 Dec; 2(6):312-9. PubMed ID: 10470463
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet?
    Silverstein MJ; Craig PH; Lagios MD; Waisman JK; Lewinsky BS; Colburn WJ; Poller DN
    Cancer; 1996 Sep; 78(5):1138-40. PubMed ID: 8780555
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ductal carcinoma in situ of the breast].
    Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B
    Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402
    [No Abstract]   [Full Text] [Related]  

  • 8. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
    Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
    Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus conference on the classification of ductal carcinoma in situ.
    Hum Pathol; 1997 Nov; 28(11):1221-5. PubMed ID: 9385925
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?
    DeCensi A; Pruneri G; Guerrieri-Gonzaga A
    J Clin Oncol; 2012 Apr; 30(12):1384-6. PubMed ID: 22393083
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma.
    Lê MG; Arriagada R; Spielmann M; Guinebretière JM; Rochard F
    Cancer; 2002 Jun; 94(11):2813-20. PubMed ID: 12115367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
    Wärnberg F; Bergh J; Zack M; Holmberg L
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.
    Fisher ER; Land SR; Saad RS; Fisher B; Wickerham DL; Wang M; Costantino JP; Wolmark N
    Am J Clin Pathol; 2007 Jul; 128(1):86-91. PubMed ID: 17580274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).
    Gupta SK; Douglas-Jones AG; Fenn N; Morgan JM; Mansel RE
    Cancer; 1997 Nov; 80(9):1740-5. PubMed ID: 9351542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast.
    Romero L; Klein L; Ye W; Holmes D; Soni R; Silberman H; Lagios MD; Silverstein MJ
    Am J Surg; 2004 Oct; 188(4):371-6. PubMed ID: 15474428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histological margin and residual disease assessment for breast carcinoma].
    Sigal-Zafrani B; Fourquet A; Vincent-Salomon A; Fréneaux P; Génin P; Rosty C; Sastre-Garau X
    Cancer Radiother; 2003 Nov; 7 Suppl 1():120s-123s. PubMed ID: 15124553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
    Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
    Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of in situ carcinoma of the breast: lobular and ductal origin.
    White RE; Bland KI
    R I Med; 1995 Sep; 78(9):242-5. PubMed ID: 7579718
    [No Abstract]   [Full Text] [Related]  

  • 19. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ.
    Baltayan A; Naritoku WY; Chaiwun B; Tsao-Wei DD; Groshen S; Hern RA; Gusterson BA; Taylor CR; Imam SA
    Anticancer Res; 2002; 22(5):2933-7. PubMed ID: 12530020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The receptor expression pattern in ductal carcinoma in situ predicts recurrence.
    Kepple J; Henry-Tillman RS; Klimberg VS; Layeeque R; Siegel E; Westbrook K; Korourian S
    Am J Surg; 2006 Jul; 192(1):68-71. PubMed ID: 16769278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.